Danimer Scientific, Inc. Stock News

Danimer Scientific (DNMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The heavy selling pressure might have exhausted for Danimer Scientific (DNMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street

Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript

Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.28 per share a year ago.

Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2023 Earnings Call Transcript November 14, 2023 4:30 PM ET Company Participants James Palczynski - IR Steve Croskrey - Chairman and CEO Mike Hajost - CFO Confe

Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.30 per share a year ago.

Danimer Scientific (DNMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production o

Danimer Scientific (DNMR) and CPChem collaborate again to explore numerous high-volume polymer applications utilizing Rinnovo materials.

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production o

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of

Danimer Scientific, Inc. (NYSE:DNMR ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants James Palczynski - IR Stephen Croskrey - CEO & Chairman Michael Hajost - CFO Confere

Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.26 per share a year ago.

The basic materials sector is the backbone of any economy because almost every industry needs basic materials for their operations.

The bioplastics company is building scale thanks to a new manufacturing facility. Management is projecting improving margins in 2023.